JSNM2024/JSNMT2024

Presentation information

[JSNM]Oral

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » 一般演題

Oral 22:RI Therapy・Thyroid, MIBG, Radium Chloride

Fri. Nov 8, 2024 8:50 AM - 9:50 AM Room 2 (5F 503, Conference Center, PACIFICO Yokohama)

座長:阿部 光一郎(東京医科大学)、三宅 可奈江(京都大学大学院医学研究科 高度医用画像学講座)

[2-MO22-2] Heterogeneity of NIS expression impairs RAI efficacy in thyroid cancer: An in vitro study

Hiroki Tanaka1、Sho Koyasu1、Hideaki Hirashima2、Yoichi Shimizu1、Tadashi Watabe3、Kazuko Kaneda-Nakashima4、Makoto Hosono5 (1.Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan、2.Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan、3.Department of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka, Japan、4.Institute for Radiation Sciences, Osaka University, Osaka, Japan、5.Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka, Japan)

Abstract password authentication.

The password is listed on page 9 of the Program Book.

Password